Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2008-03-31
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake
NCT03154606
Satiating Effects of Isolated Soy Proteins
NCT01731197
Effects of Consuming Protein Shakes, Varying in Protein Source, on Appetite, Satiety and Energy Intake
NCT03132376
Casinomacropeptide and Satiety
NCT01587911
The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake: A Clinical Screening Study
NCT03595436
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Casein
Casein-enriched diet
Subjects consume for 9 days a supplement of 30g/d of casein
MSP
Milk soluble protein-enriched diet
Subjects consume for 9 days a supplement of 30g/d of milk soluble protein
Casein/MSP
Casein and milk soluble proteins-enriched diet
Subjects consume for 9 days a supplement of 30g/d of a mix of casein and milk soluble protein
Soy protein
Soy proteins-enriched diet
Subjects consume for 9 days a supplement of 30g/d of soy protein
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Casein-enriched diet
Subjects consume for 9 days a supplement of 30g/d of casein
Milk soluble protein-enriched diet
Subjects consume for 9 days a supplement of 30g/d of milk soluble protein
Casein and milk soluble proteins-enriched diet
Subjects consume for 9 days a supplement of 30g/d of a mix of casein and milk soluble protein
Soy proteins-enriched diet
Subjects consume for 9 days a supplement of 30g/d of soy protein
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Agency, France
OTHER
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert Benamouzig
Manager of the HNRC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de recherche sur volontaires
Bobigny, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Marsset-Baglieri A, Fromentin G, Airinei G, Pedersen C, Leonil J, Piedcoq J, Remond D, Benamouzig R, Tome D, Gaudichon C. Milk protein fractions moderately extend the duration of satiety compared with carbohydrates independently of their digestive kinetics in overweight subjects. Br J Nutr. 2014 Aug 28;112(4):557-64. doi: 10.1017/S0007114514001470. Epub 2014 Jun 26.
Boutrou R, Gaudichon C, Dupont D, Jardin J, Airinei G, Marsset-Baglieri A, Benamouzig R, Tome D, Leonil J. Sequential release of milk protein-derived bioactive peptides in the jejunum in healthy humans. Am J Clin Nutr. 2013 Jun;97(6):1314-23. doi: 10.3945/ajcn.112.055202. Epub 2013 Apr 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SURPROL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.